Poster presentation at the ASCO Genitourinary Cancers Symposium titled, “[225Ac]Ac-AKY-1189, a Nectin-4-Targeted Radiopharmaceutical, in Patients With Previously Treated Locally Advanced or Metastatic Solid Tumors: Phase 1b NECTINIUM-2 Study”